Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

New Form SCHEDULE 13G/A - C4 Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0002050709-26-000022 <b>Size:</b> 81 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

General Announcement: INTRACO LIMITED ISSUED COMMERCIAL PAPERS DENOMINATED IN SGD AND USD IN DIGITAL SECURITIES

New Form 3 - GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001383046-26-000003 <b>Size:</b> 3 KB

New Form SCHEDULE 13G/A - TELA Bio, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-096813 <b>Size:</b> 8 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001918704-26-023790 <b>Size:</b> 413 KB

New Form N-PX - Western Asset High Yield Opportunity Fund Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-351486 <b>Size:</b> 3 KB

New Form N-PX - Western Asset Investment Grade Opportunity Trust Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-351485 <b>Size:</b> 3 KB

New Form 3 - Cinemark Holdings, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-351479 <b>Size:</b> 2 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001213900-26-089716 <b>Size:</b> 150 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form 8-A12B - HSBC HOLDINGS PLC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-351476 <b>Size:</b> 417 KB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001839882-26-040008 <b>Size:</b> 427 KB

New Form SCHEDULE 13G - Concentrix Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000930413-26-002515 <b>Size:</b> 23 KB